How is generative artificial intelligence (GenAI) used in medical publications now? What is the potential?
Lumanity convened a multidisciplinary group of stakeholders – including publishers, editors, ISMPP, patients and advocates, and pharma/biotech – who share perspectives on the role and value of AI in medical publications today and tomorrow.
Our discussion highlights areas of ambiguity and sheds light on the transformative potential of GenAI in scientific exchange.
Complete this form to download the summary report from our expert panel discussion.
Expert panel:
Birgit Bauer, Social Media and Digital Health Expert, Patient Expert, Journalist, Speaker, Manufaktur für Antworten UG, Germany; Founder and Coordinator, Data Saves Lives Germany
Lara Bloom, CNE, President/CEO, The Ehlers-Danlos Society; Academic Affiliate Professor of Practice in Patient Engagement and Global Collaboration, Penn State College of Medicine
Sam Cavana, BSc, Head of Publishing Solutions, Taylor & Francis
David Ginkel, MS, MBA, Global Head of Publications BPM, AstraZeneca
Anthony Guethert, BA, Chief Technology Officer, Lumanity
John Howley, PharmD, President, Medical Communications, Lumanity
Claudine Kiffer, Senior Editorial Director, Oncology, Conexiant
Elia Lima-Walton, MD, PA, Publisher, Clinician, Data Science Expert
(Formerly: Director, Data Science and Clinical Analytics, Elsevier Health)
Robert Matheis, PhD, MA, President and Chief Executive Officer, International Society for Medical Publication Professionals (ISMPP)
Sven Schwemmers, PhD, MSc, Global Scientific Communications Director,
F. Hoffmann-La Roche AG
Moderator
Tim Becker, PharmD, EVP, Creative Scientific Solutions, Lumanity
Access the summary report
"*" indicates required fields
